Cite

HARVARD Citation

    Chan, G. et al. (n.d.). ADALIMUMAB IN THE MAINTENANCE OF REMISSION FOR INFLAMMATORY BOWEL DISEASE: NEED FOR WEIGHT-BASED DOSING?. Gut. p. A18. [Online]. 
  
Back to record